Literature DB >> 19552953

The role of nitric oxide in the inhibitory effect of ghrelin against penicillin-induced epileptiform activity in rat.

Ali Aslan1, Mehmet Yildirim, Mustafa Ayyildiz, Ayla Güven, Erdal Agar.   

Abstract

Ghrelin, a gastric peptide with key action on food intake, has been recently recognized as a potential antiepileptic agent. In the present study, we investigated the involvement of nitric oxide in the effect of ghrelin on penicillin-induced epileptiform activity in rat. Thirty minutes after penicillin injection, ghrelin, at doses of 0.5, 1, 2 microg, was administered intracerebroventricularly (i.c.v.). Ghrelin, at a dose of 1 microg, significantly decreased the mean frequency of epileptiform activity without changing the amplitude whereas other doses of ghrelin (0.5 and 2 microg) did not alter either the mean of frequency or amplitude of epileptiform activity. The effects of systemic administration of nitric oxide synthase (NOS) inhibitors, non-selective N(G)-nitro-l-arginine methyl ester (l-NAME), selective neuronal NOS inhibitor, 7-nitroindazole (7-NI) and NO substrate, l-arginine on the anticonvulsive effects of ghrelin were investigated. The administration of l-NAME (60 mg/kg, i.p.), 15 min before ghrelin (1microg) application, reversed the anti-epileptiform effects of ghrelin whereas 7-NI (40 mg/kg, i.p.) did not influence it. The present study provides electrophysiological evidence that the intracerebroventricular injection of ghrelin has an inhibitory effect against epileptiform activity in the penicillin model of epilepsy. The anti-epileptiform activity of ghrelin was reversed by nonspecific nitric oxide synthase inhibitor l-NAME, but not selective neuronal nitric oxide synthase inhibitor 7-NI, indicating that ghrelin requires activation of endothelial-NOS/NO route in the brain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19552953     DOI: 10.1016/j.npep.2009.05.005

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  GABAB Receptor Blockade Prevents Antiepileptic Action of Ghrelin in the Rat Hippocampus.

Authors:  Zohreh Ataie; Shirin Babri; Mina Ghahramanian Golzar; Hadi Ebrahimi; Fariba Mirzaie; Gisou Mohaddes
Journal:  Adv Pharm Bull       Date:  2013-08-20

2.  NPY Receptors Blockade Prevents Anticonvulsant Action of Ghrelin in the Hippocampus of Rat.

Authors:  Mina Ghahramanian Golzar; Shirin Babri; Zohre Ataie; Hadi Ebrahimi; Fariba Mirzaie; Gisou Mohaddes
Journal:  Adv Pharm Bull       Date:  2013-08-20

3.  Inactivation of the constitutively active ghrelin receptor attenuates limbic seizure activity in rodents.

Authors:  Jeanelle Portelli; Leen Thielemans; Luc Ver Donck; Ellen Loyens; Jessica Coppens; Najat Aourz; Jeroen Aerssens; Katia Vermoesen; Ralph Clinckers; Anneleen Schallier; Yvette Michotte; Dieder Moechars; Graham L Collingridge; Zuner A Bortolotto; Ilse Smolders
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

4.  Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model.

Authors:  Nagehan Can; Onur Catak; Burak Turgut; Tamer Demir; Nevin Ilhan; Tuncay Kuloglu; Ibrahim Hanifi Ozercan
Journal:  Drug Des Devel Ther       Date:  2015-06-02       Impact factor: 4.162

Review 5.  Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Authors:  Carmela Giordano; Maddalena Marchiò; Elena Timofeeva; Giuseppe Biagini
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

6.  The effects of treadmill exercise on penicillin-induced epileptiform activity.

Authors:  Yildirim Kayacan; Erkut Tutkun; Gokhan Arslan; Mustafa Ayyildiz; Erdal Agar
Journal:  Arch Med Sci       Date:  2016-08-24       Impact factor: 3.318

7.  Involvement of PPARγ in the Anticonvulsant Activity of EP-80317, a Ghrelin Receptor Antagonist.

Authors:  Chiara Lucchi; Anna M Costa; Carmela Giordano; Giulia Curia; Marika Piat; Giuseppina Leo; Jonathan Vinet; Luc Brunel; Jean-Alain Fehrentz; Jean Martinez; Antonio Torsello; Giuseppe Biagini
Journal:  Front Pharmacol       Date:  2017-09-22       Impact factor: 5.810

Review 8.  Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy.

Authors:  An Buckinx; Dimitri De Bundel; Ron Kooijman; Ilse Smolders
Journal:  Biomedicines       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.